MSAM
JAZZ icon

Moloney Securities Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Moloney Securities Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,420
Closed -$257K – 513
2025
Q2 		$257K Sell
2,420
-2,390
-50% -$260K 0.03% 397
2025
Q1 		$597K Buy
4,810
+1,039
+28% +$136K 0.08% 230
2024
Q4 		$464K Buy
+3,771
New +$444K 0.06% 272
2018
Q3 		– Sell
-1,185
Closed -$204K – 312
2018
Q2 		$204K Buy
+1,185
New +$194K 0.08% 268

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Moloney Securities Asset Management's JAZZ Position: Q3 2025 in Review

Moloney Securities Asset Management sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 2,420 shares — an estimated $257K sold.

Moloney Securities Asset Management first reported a position in JAZZ in Q2 2018 and held it in 4 quarters. The position peaked at $597K in Q1 2025. 502 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Moloney Securities Asset Management reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Moloney Securities Asset Management sold 2,420 Jazz Pharmaceuticals shares in Q3 2025, an estimated $257K.
  • Moloney Securities Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2018 and held it in 4 quarters.
  • Moloney Securities Asset Management's Jazz Pharmaceuticals position peaked at $597K in Q1 2025.
  • 502 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Moloney Securities Asset Management's 13F filing for Q3 2025, filed 5 Nov 2025.